Alloantigen specific T regulatory cells in transplant tolerance

International Immunopharmacology

Volumn 9, Issue 5, 2009, Pages 570-574

  Hall, Bruce M ^a,b   Tran, Giang ^a,b   Hodgkinson, Suzanne J ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

TH1; Transplant; Tregs

Indexed keywords

ALLOANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CONCANAVALIN A; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 5 RECEPTOR ALPHA; MESSENGER RNA; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; T LYMPHOCYTE RECEPTOR;

ANTIGEN SPECIFICITY; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CYTOKINE PRODUCTION; GENE EXPRESSION; GRAFT REJECTION; GRAFT SURVIVAL; HEART GRAFT; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SUPERNATANT; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL; TRANSPLANTATION TOLERANCE; ANIMAL; CELL DIFFERENTIATION; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; HEART TRANSPLANTATION; IMMUNOLOGY; METABOLISM; MOUSE; PATHOLOGY; RAT;

ANIMALS; ANTIGENS, CD4; CELL DIFFERENTIATION; CYTOKINES; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HEART TRANSPLANTATION; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; ISOANTIGENS; MICE; RATS; T-CELL ANTIGEN RECEPTOR SPECIFICITY; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH2 CELLS; TRANSPLANTATION TOLERANCE;

EID: 63549086511     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2009.01.016     Document Type: Article

References (71)

1. Anderson D., Billingham R.E., Lampkin G.H., and Medawar P.B. The use of skin grafting to distinguish between monozygotic and dizygotic twins in cattle. Heredity 5 (1951) 379-397
2. Billingham R.E., Brent L., and Medawar P.B. Actively acquired tolerance of foreign cells. Nature 172 (1953) 603-607
3. Ilstad S.T., Wren S.M., Bluestone J.A., Barbieri S.A., and Sachs D.H. Characterization of mixed allogeneic chimeras: immunocompetence, in vitro reactivity, and genetic specificity of tolerance. J Exp Med 162 (1985) 231-244
4. Slavin S., Reitz B., Bieber C.P., Kaplan H.S., and Strober S. Transplantation tolerance in adult rats using total lymphoid irradiation: permanent survival of skin, heart, and marrow allografts. J Exp Med 147 (1978) 700-707
5. Sykes M., Preffer F., McAfee S., Saidman S.L., Weymouth D., Andrews D.M., et al. Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation. Lancet 353 (1999 May 22) 1755-1759
6. Sharabi Y., and Sachs D.H. Mixed chimerism and permanent specific transplantation tolerance induced by a non-lethal preparative regime. J Exp Med 169 (1989) 493-502
7. Kawai T., Cosimi A.B., Spitzer T.R., Tolkoff-Rubin N., Suthanthiran M., Saidman S.L., et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 358 (2008) 353-361
8. Scandling J.D., Busque S., Dejbakhsh-Jones S., Benike C., Millan M.T., Shizuru J.A., et al. Tolerance and chimerism after renal and hematopoietic-cell transplantation. N Engl J Med 358 (2008) 362-368
9. Dorsch S., and Roser B. T cells mediate transplantation tolerance. Nature 258 (1975) 233-235
10. Dorsch S., and Roser B. Recirculating suppressor T cells in transplantation tolerance. J Exp Med 145 (1977) 1144-1157
11. Dorsch S., and Roser B. Suppressor cells in transplantation tolerance. II. Identification and probable mode of action of chimeric suppressor cells. Transplantation 33 (1982) 525-539
12. Dorsch S., and Roser B. Suppressor cells in transplantation tolerance. I. Analysis of the suppressor status of neonatally tolerised rats. Transplantation 33 (1982) 518-524
13. Batchelor J.R., and Welsh K.I. Mechanisms of enhancement of kidney allograft survival. A form of operational tolerance. Brit Med Bull 32 (1976) 113-117
14. Fabre J.W., and Morris P.J. Passive enhancement of homozygous renal allografts in the rat. Transplantation 18 (1974 Nov) 429-435
15. Stuart F.P., McKearn T.J., Weiss A., and Fitch F.W. Suppression of rat renal allograft rejection by antigen and antibody. Immunol Rev 49 (1980) 127-163
16. Dallman M.J., Shiho O., Page T.H., Wood K.J., and Morris P.J. Peripheral tolerance to alloantigen results from altered regulation of the interleukin 2 pathway. J Exp Med 173 (1991) 79-87
17. Dallman M.J., Wood K.J., and Morris P.J. Specific cytotoxic T cells are found in non-rejected kidneys of blood transfused rats. J Exp Med 165 (1987) 566-570
18. Batchelor J.R., Phillips B.E., and Grennan D. Suppressor cells and their role in the survival of immunologically enhanced rat kidney allografts. Transplantation 37 (1984) 43-48
19. Lechler R.I., and Batchelor J.R. Immunogenicity of retransplanted rat kidney allografts. Effect of inducing chimerism in the first recipient and quantitative studies on immunosuppression of the second recipient. J Exp Med 156 (1982) 1835-1841
20. Pearce N.W., Dorsch S.E., and Hall B.M. Mechanisms maintaining antibody-induced enhancement of allografts. III. Examination of graft-versus-host reactivity of T cell subsets from rats with long-surviving grafts. Transplantation 50 (1990) 1078-1081
21. Hall B.M., Jelbart M.E., and Dorsch S.E. Alloreactivity in rats treated with cyclosporin A to prolong cardiac graft survival. Transplant Proc 15 (1983) 504-507
22. Kostakis A.J., White J.G., and Calne R.Y. Prolongation of rat heart allograft survival by cyclosporin A. IRCS MedSci LibrCompend 5 (1977) 280
23. Mjornstedt L., Olausson M., Lindholm L., Soderstrom T., and Brynger H. Mechanisms of transplantation tolerance in anti-lymphocyte globulin treated rats. Transplantation 44 (1987) 669-673
24. Pearce N.W., Berger M.F., Gurley K.E., Spinelli A., and Hall B.M. Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. VI. In vitro alloreactivity of T cell subsets from rats with long-surviving allografts. Transplantation 55 (1993) 380-389
25. Pearce N.W., Dorsch S.E., and Hall B.M. Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. IV. Examination of T cell subsets in graft-versus-host assays [published erratum appears in Transplantation 1990;50: 910]. Transplantation 50 (1990) 493-497
26. Nicolls M.R., Aversa G.G., Pearce N.W., Spinelli A., Berger M.F., Gurley K.E., et al. Induction of long-term specific tolerance to allografts in rats by therapy with an anti-CD3-like monoclonal antibody. Transplantation 55 (1993) 459-468
27. Tsuchida M., Hirahara H., Matsumoto Y., Abo T., and Eguchi S. Induction of specific unresponsiveness to cardiac allografts by short-term administration of anti-T cell receptor alpha beta antibody. Transplantation 57 (1994) 256-262
28. Cobbold S.P., Martin G., Qin S., and Waldmann H. Monoclonal antibodies to promote engraftment and tissue graft tolerance. Nature 323 (1986) 164-168
29. Herbert J., and Roser B. Strategies of monoclonal antibody therapy that induce permanent tolerance of organ transplants. Transplantation 46 (1988) 128S-134S
30. Hirahara H., Tsuchida M., Watanabe T., Haga M., Matsumoto Y., Abo T., et al. Long-term survival of cardiac allografts in rats treated before and after surgery with monoclonal antibody to CD2. Transplantation 59 (1995) 85-90
31. Isobe M., Yagita H., Okumura K., and Ihara A. Specific acceptance of cardiac allografts after treatment with antibodies to ICAM-1 and LFA-1. Science 255 (1992) 1125-1127
32. Habitcht S., and Sayegh M. T cell co-stimulatory pathways. Curr Opin Organ Transplant 13 (2008) 17-22
33. Hall B.M. Mechanisms of induction of tolerance to organ allografts. Crit Rev Immunol 20 (2000) 267-272
34. Hall B., Roser B., and Dorsch S.E. A model for study of the cellular mechanisms that maintain long-term enhancement of cardiac graft survival. Transplant Proc 11 (1979) 958-961
35. Hall B. The cellular basis of the maintenance of passive enhancement. Transplant Proc 13 (1981) 403-406
36. Hall B.M. Mechanisms maintaining enhancement of allografts. I. Demonstration of a specific suppressor cell. J Exp Med 161 (1985) 123-133
37. Gershon R.K., Cohen P., Hencin R., and Liebhaber S.A. Suppressor T cells. J Immunol 108 (1972) 586-590
38. Gershon R.K., and Kondo K. Infectious immunological tolerance. Immunology 21 (1971) 903-914
39. Dallman M.J., and Mason D.W. Role of thymus-derived and thymus-independent cells in murine skin allograft rejection. Transplantation 33 (1982) 221-223
40. Hall B.M., de Saxe I.S., and Dorsch S.E. The cellular basis of allograft rejection in vivo. III. Restoration of first-set rejection of heart grafts by T helper cells in irradiated rats. Transplantation 36 (1983) 700-705
41. Loveland B.E., Hogarth P.M., Ceredig R.H., and McKenzie I.F.C. Cells mediating graft rejection in mice. I. Ly-1+ cells mediate skin graft rejection. J Exp Med 153 (1981) 1044-1052
42. Hall B.M., Gurley K.E., and Dorsch S.E. The possible role of cytotoxic T cells in the mediation of first-set allograft rejection. Transplantation 40 (1985) 336-339
43. Rosenberg A.S., Mizuochi T., Sharrow S.O., and Singer A. Phenotype, specificity, and function of T cell subsets and T cell interactions involved in skin allograft rejection. J Exp Med 165 (1987) 1296-1315
44. Hall B.M. Cells mediating allograft rejection [published erratum appears in transplantation 1991;52: 936]. Transplantation 51 (1991) 1141-1151
45. Hall B.M., Jelbart M.E., Gurley K.E., and Dorsch S.E. Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. Mediation of specific suppression by T helper/inducer cells. J Exp Med 162 (1985) 1683-1694
46. Hall B.M., Pearce N.W., Gurley K.E., and Dorsch S.E. Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. III. Further characterization of the CD4+ suppressor cell and its mechanisms of action. J Exp Med 171 (1990) 141-157
47. Pearce N.W., Spinelli A., Gurley K.E., Dorsch S.E., and Hall B.M. Mechanisms maintaining antibody-induced enhancement of allografts. II. Mediation of specific suppression by short lived CD4+ T cells. J Immunol 143 (1989) 499-506
48. Pearce N.W., Spinelli A., Gurley K.E., and Hall B.M. Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporin V. Dependence of the CD4+ suppressor cell on the presence of alloantigen and cytokines, including interleukin-2. Transplantation 55 (1993) 374-380
49. Qin S., Cobbold S.P., Pope H., Elliott J., Kioussis D., Davies J., et al. Infectious" transplantation tolerance. Science 259 (1993) 974-977
50. Green D.R., Flood P.M., and Gershon R.K. Immunoregulatory T cell pathways. Ann Rev Immunol 1 (1983) 439-463
51. Green D.R., and Webb D.R. Saying the 'S' word in public. Immunol Today 14 (1993) 523-525
52. Moller G. Do suppressor T cells exist?. Scand J Immunol 27 (1988) 247-250
53. Hall B.M., Fava L., Chen J., Plain K.M., Boyd R.A., Spicer S.T., et al. Anti-CD4 monoclonal antibody-induced tolerance to MHC-incompatible cardiac allografts maintained by CD4+ suppressor T cells that are not dependent upon IL-4. J Immunol 161 (1998) 5147-5156
54. Plain K.M., Boyd R., Verma N., Robinson C., Tran G., Hodgkinson S.J., et al. Transplant tolerance associated with a Th1 response and not broken by IL-4. IL-5 and TGF-beta blockade or Th1 cytokine administration. Transplantation 83 (2007) 764-773
55. Hall B.M., Plain K.M., Verma N.D., Tran G., Boyd R., Robinson C.M., et al. Transfer of allograft-specific tolerance requires CD4+CD25+T cells, but not IL-4 or TGF-β and cannot induce tolerance to linked antigens. Transplantation 83 (2007) 1075-1084
56. Cobbold S.P., Nolan K.F., Graca L., Castejon R., Le Moine A., Frewin M., et al. Regulatory T cells and dendritic cells in transplantation tolerance: molecular markers and mechanisms. Immunol Rev 196 (2003) 109-124
57. Kupiec-Weglinski J.W., Padberg W.M., Uhteg L.C., Ma L., Lord R.H., Araneda D., et al. Selective immunosuppression with interleukin-2 receptor-targeted therapy: helper and suppressor cell activity in rat recipients of cardiac allografts. Eur J Immunol 17 (1987) 313-319
58. Soulillou J.P. Biological reagents for immunosuppressants. Transplant Proc 27 (1995) 106-108
59. Hall B.M. Transplantation tolerance: a 1988 perspective. Transplant Proc 21 (1989) 816-819
60. Hall B.M., de Saxe I., and Dorsch S.E. The role of the host thymus in the mediation of allograft rejection in irradiated rats restored with helper T cells. Transplant Proc 16 (1984) 952-953
61. Nomura M., Plain K.M., Verma N., Robinson C., Boyd R., Hodgkinson S.J., et al. The cellular basis of cardiac allograft rejection. IX. Ratio of naive CD4+CD25+ T cells/CD4+CD25- T cells determines rejection or tolerance. Transpl Immunol 15 (2006) 311-318
62. Hall B.M., Robinson C.M., Plain K.M., Verma N.D., Carter N., Boyd R., et al. Studies on naïve CD4+CD25+T cells inhibition of naïve CD4+CD25-T cells in mixed lymphocyte cultures. Transpl Immunol 18 (2008) 291-300
63. Hoffmann P., Ermann J., Edinger M., Fathman C.G., and Strober S. Donor-type CD4+CD25+ regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J Exp Med 196 (2002 Aug 5) 389-399
64. Taylor P.A., Lees C.J., and Blazar B.R. The infusion of ex vivo activated and expanded CD4+CD25+ immune regulatory cells inhibits graft-versus-host disease lethality. Blood 99 (2002 May 15) 3493-3499
65. Golshayan D., Jiang S., Tsang J., Garin M.I., Mottet C., and Lechler R.I. In vitro-expanded donor alloantigen-specific CD4+CD25+ regulatory T cells promote experimental transplantation tolerance. Blood 109 (2007) 827-835
66. Nishimura E., Sakihama T., Setoguchi R., Tanaka K., and Sakaguchi S. Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+CD25+CD4+ regulatory T cells. Int Immunol 16 (2004) 1189-1201
67. Verma N., Plain K., Nomura M., Tran G., Robinson C., Boyd R., et al. CD4+CD25+T cells alloactivated ex vivo by IL-2 or IL-4, become potent alloantigen specific inhibitors of rejection with different phenotypes, suggesting Th1 and Th2 responses activate by separate pathways. Blood 113 (2009) 479-487
68. Feng G., Gao W., Strom T.B., Oukka M., Francis R.S., Wood K.J., et al. Exogenous IFN-gamma ex vivo shapes the alloreactive T-cell repertoire by inhibition of Th17 responses and generation of functional Foxp3+ regulatory T cells. Eur J Immunol 38 (2008) 2512-2527
69. Feng G., Wood K.J., and Bushell A. Interferon-gamma conditioning ex vivo generates CD25+CD62L+Foxp3+ regulatory T cells that prevent allograft rejection: potential avenues for cellular therapy. Transplantation 86 (2008) 578-589
70. Sawitzki B., Kingsley C.I., Oliveira V., Karim M., Herber M., and Wood K.J. IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo. J Exp Med 201 (2005) 1925-1935
71. He X.Y., Verma N., Chen J., Robinson C., Boyd R., and Hall B.M. IL-5 prolongs allograft survival by down-regulating IL-2 and IFN-gamma cytokines. Transplant Proc 33 (2001) 703-704